摘要
目的:阐明中国药用甘草物种之间的界限,为甘草资源开发和优良品种选育奠定基础。方法:PCR扩增、DNA序列测定、分支分析。结果:获得我国甘草属8种(变种)植物的ITS序列,得到中国药用甘草的系统发育树。结论:支持黄甘草归并入胀果甘草、密腺甘草归并入光果甘草;支持无腺毛甘草为独立的物种。
Objective： Elucidate the medicinal licorice species circumscription in order to develop licorice resources in China and select new cultivars. Method： PCR amplification, DNA sequencing and cladistic analysis. Result： Acquire the ITS sequences and phylngenetic tree of 8 licorice species. Conclusion： According to results Glycyrrhiza eurycarpa and G. glabra var. glandulosa should be combined into G. inflate and G. glabra respectively and G. egladulosa is an independent species.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2005年第22期1736-1738,共3页
China Journal of Chinese Materia Medica
基金
国家自然科学基金资助项目(30400588)
关键词
药用甘草
ITS序列
medicinal licorice
ITS sequence
